REACH: Hydroxyurea for SCA
REACH: Long-term Analysis of Dose-Optimized Hydroxyurea for Treatment of Pediatric Patients With Sickle Cell Anemia in Sub-Saharan Africa

Released: December 12, 2023

Activity

Progress
1
Course Completed